The House Energy and Commerce Committee is collecting information on the government's oversight of the 340B drug discount program with an eye to identifying potential abuses by safety net hospitals and other providers that are benefitting from the discounts.
The committee is weighing a hearing on the issue though no date for one has been announced. (Also see "
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?